Sugawara Katsura, Hata Ken-ichiro
Japan Tissue Engineering Co., Ltd., Research and Development.
Clin Calcium. 2008 Dec;18(12):1751-6.
Recently, regenerative medicine has attracted attention worldwide and also in Japan. Several guidelines on regenerative medicine have been released from the Japanese regulatory agency. Within the guidelines, Japan Tissue Engineering Co., Ltd. has been developing tissue-engineered products of cultured epidermis, cartilage and cornea using autologous cells. In this paper, we describe the industrialization of regenerative medicine as well as regulations based on our experiences of the culture cartilage development.
近年来，再生医学在全球范围内，包括在日本，都备受关注。日本监管机构发布了多项关于再生医学的指南。在这些指南框架内，日本组织工程有限公司一直在利用自体细胞研发培养表皮、软骨和角膜的组织工程产品。在本文中，我们将基于培养软骨开发的经验，描述再生医学的产业化以及相关法规。
